一种快速床旁测量肾小球滤过率的新方法
本研究开发了一种新型外源性生物标志物可见荧光注射剂(VFI),通过单次静脉注射后基于血浆药代动力学测定血浆容量和mGFR。在32名肾功能正常或CKD 3-4期成人中,VFI法mGFR与iohexol法mGFR高度线性相关,且耐受性良好、无严重不良事件、重复性高。
要点
- VFI法仅需3小时内3次0.5ml采血即可床旁测定mGFR
- VFI法mGFR与iohexol法mGFR在所有参与者中呈密切线性相关
- VFI注射耐受良好,连续日注射亦安全,无严重不良事件
核心结论
- VFI法可在床旁快速测定mGFR,同时保持患者安全、测量准确性和重复性。
研究设计与样本
- 前瞻性、开放标签研究,纳入32名成人,其中肾功能正常16例、CKD 3期8例、CKD 4期8例。
- 比较VFI法mGFR与iohexol血浆消失法mGFR,8名健康参与者24小时后重复注射VFI。
主要发现
- VFI法mGFR值与iohexol法mGFR值在所有参与者中呈密切线性相关。
- VFI注射耐受良好,包括连续日注射,未报告严重不良事件。
- VFI法mGFR具有高度重复性。
关键数值与推荐
- VFI法mGFR需3小时内3次0.5ml采血,iohexol法mGFR需6小时内5次采样。
- VFI由150-kD罗丹明衍生物和5-kD荧光素羧甲基化葡聚糖组成,单次静脉注射后分别测定血浆容量和mGFR。
临床怎么用
- VFI法为床旁快速测定mGFR提供了新选择,适用于需要准确mGFR的临床情境和特定患者群体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Direct quantitative measurement of GFR (mGFR) remains a specialized task primarily performed in research settings. Multiple formulas for estimating GFR have been developed that use the readily available endogenous biomarkers creatinine and/or cystatin C. However, eGFR formulas have limitations, and an accurate mGFR is necessary in some clinical situations and for certain patient populations. We conducted a prospective, open-label study to evaluate a novel rapid technique for determining plasma volume and mGFR.Methods We developed a new exogenous biomarker, visible fluorescent injectate (VFI), consisting of a large 150-kD rhodamine derivative and small 5-kD fluorescein carboxymethylated dextrans. After a single intravenous injection of VFI, plasma volume and mGFR can be determined on the basis of the plasma pharmacokinetics of the rhodamine derivative and fluorescein carboxymethylated dextrans, respectively. In this study involving 32 adults with normal kidney function (n=16), CKD stage 3 (n=8), or CKD stage 4 (n=8), we compared VFI-based mGFR values with values obtained by measuring iohexol plasma disappearance. VFI-based mGFR required three 0.5-ml blood draws over 3 hours; iohexol-based mGFR required five samples taken over 6 hours. Eight healthy participants received repeat VFI injections at 24 hours.Results VFI-based mGFR values showed close linear correlation with the iohexol-based mGFR values in all participants. Injections were well tolerated, including when given on consecutive days. No serious adverse events were reported. VFI-based mGFR was highly reproducible.Conclusions The VFI-based approach allows for the rapid determination of mGFR at the bedside while maintaining patient safety and measurement accuracy and reproducibility.
引用
- Rizk DV, Meier D, Sandoval RM, et al. A Novel Method for Rapid Bedside Measurement of GFR. J Am Soc Nephrol. 2018. PMID: 29748326. doi:10.1681/ASN.2018020160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。